122
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations

, , , , , , , , & show all
Pages 5683-5691 | Published online: 09 Nov 2012

References

  • KokoskaERSmithGSWolffABDeshpandeYMillerTANonsteroidal anti-inflammatory drugs attenuate epidermal growth factor-induced proliferation independent of prostaglandin synthesis inhibitionJ Surg Res199984218619210357918
  • ThunMJNSAID use and decreased risk of gastrointestinal cancersGasteroenterol Clin North Am1996252333348
  • GiardielloFMNSAID-induced polyp regression in familial adenomatous polyposis patientsGasteroenterol Clin North Am1996252349362
  • BarnesCJCameronILHardmanWELeeMNon-steroidal anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesisBr J Cancer19987745735809484814
  • FratelliMMintoMCrespiAInhibition of nuclear factor-kappaB by a nitro-derivative of flurbiprofen: a possible mechanism for anti-inflammatory and antiproliferative effectAntioxid Redox Signal20035222923512716482
  • BaronJAEpidemiology of non-steroidal anti-inflammatory drugs and cancerProg Exp Tumor Res20033712412795046
  • LangmanMJChengKKGilmanEALancashireRJEffect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research databaseBMJ200032072501642164610856067
  • WangWHHuangJQZhengGFLamSKKarlbergJWongBCNon-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysisJ Natl Cancer Inst200395231784179114652240
  • BonelliPTuccilloFMCalemmaRChanges in the gene expression profile of gastric cancer cells in response to ibuprofen: a gene pathway analysisThe Pharmacogenomics J2011116412428
  • BriggerIDubernetCCouvreurPNanoparticles in cancer therapy and diagnosisAdv Drug Deliv Rev200254563165112204596
  • WangKRuanJQianQBRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancerJ Nanobiotechnology201192321612621
  • JainKKNanotechnology-based drug delivery for cancerTechnol Cancer Res Treat20054440741616029059
  • CengelliFGrzybJAMontoroAHofmannHHanessianSJuillerat-JeanneretLSurface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecinChem Med Chem20094698899719347834
  • KuoFSubramanianBKotylaTWilsonTAYoganathanSNicolosiRJNanoemulsions of an anti-oxidant synergy formulation containing gamma tocopherol have enhanced bioavailability and anti-inflammatory propertiesIntl J Pharm20083631206213
  • ShiveMSAndersonJMBiodegradation and biocompatibility of PLA and PLGA microspheresAdv Drug Deliv Rev199728152410837562
  • FournierEPassiraniCMontero-MeneiCNBenoitJPBiocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibilityBiomaterials200324193311333112763459
  • MiddletonJCTiptonAJSynthetic biodegradable polymers as orthopedic devicesBiomaterials200021232335234611055281
  • WuLDingJIn vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineeringBiomaterials200425275821583015172494
  • BudhianASiegelSJWineyKIHaloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug contentInt J Pharm2007336236737517207944
  • TeixeiraMAlonsoMJPintoMMBarbosaCMDevelopment and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthoneEur J Pharm Biopharm200559349150015760730
  • MüllerRHJacobsCKayserONanosuspensions as particulate drug formulations in therapy: Rationale for development and what we can expect for the futureAdv Drug Deliv Rev200147131911251242
  • JainRAThe manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devicesBiomaterials200021232475249011055295
  • VertMThe complexity of PLGA-based drug delivery systemsProceedings of the International Conference on Advances in Controlled DeliveryBaltimore, MD19963236
  • John-AryankalayilMPalayoorSTCernaDFaldutoMTMagnusonSRColemanCNNS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cellsMol Cancer Ther20098126127319139136
  • YoonJCChickeringTWRosenEDPeroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiationMol Cell Biol200020145343534910866690
  • LiKQLiWLPengSYShiXYTangHLLiuYBAnti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfectionChin Med J (Eng)2004117913641369
  • LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) MethodMethods200125440240811846609
  • NkansahMKThakralDShapiroEMMagnetic poly(lactide-co-glycolide) and cellulose particles for MRI-based cell trackingMag Reson Med201165617761785
  • KocbekPObermajerNCegnarMKosJKristlJTargeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibodyJ Control Rel20071201–21826
  • CartieraMSJohnsonKMRajendranVCaplanMJSaltzmanWMThe uptake and intracellular fate of PLGA nanoparticles in epithelial cellsBiomaterials200930142790279819232712
  • YangJLeeCHParkJAntibody conjugated magnetic PLGA nanoparticles for diagnosis and treatment of breast cancerJ Mater Chem20071726952699
  • ParkJFongPMLuJPEGylated PLGA nanoparticles for the improved delivery of doxorubicinNanomedicine20095441041819341815
  • PanyamJZhouWZPrabhaSSahooSKLabhasetwarVRapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene deliveryFASEB J200216101217122612153989
  • Fernández-CarballidoAHerrero-VanrellRMolina-MartínezITPastorizaPSterilized ibuprofen-loaded poly(D,L-lactide-co-glycolide) microspheres for intra-articular administration: effect of gamma-irradiation and storageJ Microencapsul200421665366515762322
  • Fernández-CarballidoAHerrero-VanrellRMolina-MartínezITPastorizaPBiodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitroInt J Pharm20042791–2334115234792
  • KloseDSiepmannFElkharrazKSiepmannJPLGA-based drug delivery systems: importance of the type of drug and device geometryInt J Pharm20083541–29510318055140
  • PangJLuanYLiFCaiXDuJLiZIbuprofen-loaded poly(lactic-co-glycolic acid) films for controlled drug releaseInt J Nanomedicine2011665966521674021
  • PanyamJDaliMMSahooSKPolymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticlesJ Control Release2003921–217318714499195
  • BarrattGMTherapeutic applications of colloidal drug carriersPharm Sci Technolo Today20003516317110785658
  • BalaIHariharanSKumarMNPLGA nanoparticles in drug delivery: the state of the artCrit Rev Ther Drug Carrier Syst200421538742215719481